Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China · Delayed Price · Currency is CNY 5.80
+0.02 (0.35%)
Sep 23, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Market Cap
Guangdong VTR Bio-Tech has a market cap or net worth of 2.79 billion as of September 23, 2026. Its market cap has decreased by -15.82% in one year.
Market Cap
2.79B
Enterprise Value
2.39B
Revenue
814.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.80
ChartMarket Cap Chart
Since January 28, 2014, Guangdong VTR Bio-Tech's market cap has increased from 1.84B to 2.79B, an increase of 51.41%. That is a compound annual growth rate of 3.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 2.79B | -11.04% |
| Dec 31, 2025 | 3.13B | -7.12% |
| Dec 31, 2024 | 3.37B | -4.55% |
| Dec 29, 2023 | 3.53B | -4.20% |
| Dec 30, 2022 | 3.69B | -36.63% |
| Dec 31, 2021 | 5.82B | 9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hinova Pharmaceuticals | 3.07B |
| Beijing Kawin Technology Share-Holding | 3.05B |
| Baolingbao Biology | 3.02B |
| Guanhao Biotech | 2.98B |
| Zhejiang Shouxiangu Pharmaceutical | 2.96B |
| Zhejiang East Asia Pharmaceutical | 2.78B |
| Hubei Goto Biopharm Group | 2.74B |
| Shenzhen Bioeasy Biotechnology | 2.71B |